In ovarian and breast cancer cell lines that do not respond to conventional therapy, TGZ combined with the cell signaling molecule TNF-associated apoptosis-inducing ligand (TRAIL) showed effective synergistic pro-apoptosis results (Bräutigam et al., 2011; Plissonnier et al., 2017). This evidence concerns the gene TGM7 and breast carcinoma.